Shoulder Muscle Imbalance as a Risk for Shoulder Injury in Elite Adolescent Badminton Players (BADIRMS)

April 22, 2020 updated by: Joffrey DRIGNY, University Hospital, Caen

Shoulder Muscle Imbalance as a Risk for Shoulder Injury in Elite Adolescent Badminton Players : a Prospective Pilot Study

Background: To assess the impact of pre-season clinical measures and rotator muscles strength on the risk of significant shoulder injury (SSI) in elite adolescent badminton players Design: Prospective cohort study Participants: Nine elite adolescents badminton players were included and followed from September 2018 to May 2019.

Independent variables: A pre-season visit consisted in clinical and isokinetic shoulder strength testing. Isokinetic internal and external rotator shoulder muscles strength was tested at 60, 120 and 240°/s. Conventional and functional (eccentric-to-concentric) ratios (FR) were calculated. SSI collection was performed by an experienced sport physician.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

9

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Caen, France, 14000
        • CHU Caen Normandie

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The population was all the elite adolescent badminton players from a high-level club

Description

Inclusion Criteria:

  • All the elite adolescent badminton players from a high-level club.

Exclusion Criteria:

  • Players who had SSI in the 3 months prior to the isokinetic test or had shoulder surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Elite adolescent badminton players
The population was all the elite adolescent badminton players from a high-level club. We excluded players who had SSI in the 3 months prior to the isokinetic test or had shoulder surgery. They were included and followed from September 2018 to May 2019.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline Isokinetic strength testing (peak torques) at 8 months
Time Frame: Two evaluations, one preseason (september 2018) and one postseason (may 2019) visits
Shoulder rotator muscles isokinetic strength test, Measures: Peak Torque on internal rotator muscles (IR) and external rotator muscles (ER), in NM (newton.meter)
Two evaluations, one preseason (september 2018) and one postseason (may 2019) visits
Change from Baseline Isokinetic strength testing (ratios) at 8 months
Time Frame: Two evaluations, one preseason (september 2018) and one postseason (may 2019) visits
Shoulder rotator muscles isokinetic strength test, Measures: ratios between external rotator muscles (ER) and internal rotator muscles (IR) (ER:IR), in percent (%)
Two evaluations, one preseason (september 2018) and one postseason (may 2019) visits
Clinical measurements, ROM
Time Frame: One evaluation, one preseason visit (september 2018)
Shoulder internal and external rotation range of motion (ROM)
One evaluation, one preseason visit (september 2018)
Clinical measurements TAD
Time Frame: One evaluation, one preseason visit (september 2018)
table-to-acromion distance (in cm)
One evaluation, one preseason visit (september 2018)
Significant Shoulder Injury (SSI) collection (number of injury)
Time Frame: During the badminton season, the number (number, n) of injury was recorded from september 2018 to may 2019
Significant Shoulder Injury (SSI) collection for the number of injury
During the badminton season, the number (number, n) of injury was recorded from september 2018 to may 2019
Significant Shoulder Injury (SSI) collection (type of injury)
Time Frame: During the badminton season, the type of injury (number, n) was recorded from september 2018 to may 2019
Significant Shoulder Injury (SSI) collection for the type of injury
During the badminton season, the type of injury (number, n) was recorded from september 2018 to may 2019
Significant Shoulder Injury (SSI) collection (time lost from participation)
Time Frame: During the badminton season, the time lost from participation was recorded (in days) from september 2018 to may 2019
Significant Shoulder Injury (SSI) collection for time lost from participation due to the injury
During the badminton season, the time lost from participation was recorded (in days) from september 2018 to may 2019

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Joffrey DRIGNY, MD MSc, CHU Caen Normandy

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 5, 2018

Primary Completion (Actual)

September 1, 2018

Study Completion (Actual)

July 15, 2019

Study Registration Dates

First Submitted

April 20, 2020

First Submitted That Met QC Criteria

April 22, 2020

First Posted (Actual)

April 24, 2020

Study Record Updates

Last Update Posted (Actual)

April 24, 2020

Last Update Submitted That Met QC Criteria

April 22, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • BADIRMS

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Shoulder Injuries

3
Subscribe